Abanid, Viola B.
HRN: 01-45-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/13/2025
04/20/2025
IV
300mg
Q6h
T/c Acute Tonsillopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes